AN

ANI Pharmaceuticals

- NASDAQ:ANIP
Last Updated 2024-04-19
  • ANI manufactures oral solid dose products, as well as liquids and topicals.

  • Locations

    • Baudette MN

  • Total Funding (USD)

    125.0 million

  • Acquisitions (3)

    • WellSpring Pharma Services (2018)
    • BioSante Pharmaceuticals (2012)
    • ANI Pharmaceuticals (2004)

  • Security

    Type: ORD
    CUSIP: 00182C103
    ISIN: US00182C1036
Filter date
All
Bookmark Created by Last updated
There were no results found.
Filter date
All
Article Author Published
There were no results found.

Request a demo to view additional historical data, and much more.

Request Demo